As of 4:00pm ET
| +0.03 / +1.32%|
The 1 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a -13.42% decrease from the last price of 2.31.
The current consensus among 4 polled investment analysts is to Hold stock in Infinity Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.